| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Hutson Nancy J is a Director at BIOCRYST PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 4 sells.
Estimated insider holdings value: $884K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 7,000 | $7.54 | $52,780.00 | -7.5% | +0.1% | +0.5% | |
| May 20, 2024 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 5,000 | $6.38 | $31,900.00 | +6.1% | +28.2% | +68.5% | |
| Oct 3, 2023 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 10,000 | $0.86 | $8,600.00 | +12.0% | +51.9% | +57.8% | |
| Jun 14, 2023 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 12,866 | $8.04 | $103,442.64 | -13.6% | -12.6% | -21.5% | |
| Nov 17, 2022 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 30,000 | $1.33 | $39,900.00 | +56.6% | -0.7% | -29.4% | |
| Oct 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 105,000 | $15.40 | $1,617,000.00 | -61.7% | +6.7% | -10.6% | |
| Aug 16, 2021 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 3,000 | $5.68 | $17,040.00 | +30.0% | -13.7% | -72.7% | |
| Jun 10, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 23,333 | $16.86 | $393,394.38 | -26.4% | -13.1% | -42.7% | |
| Mar 12, 2021 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 5,000 | $3.11 | $15,525.00 | +100.0% | -0.6% | -38.5% | |
| May 20, 2020 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 5,000 | $1.85 | $9,250.00 | New | - | - |